CVS Group plc SAYE Option Scheme & PDMR Dealing (6817H)
25 Novembre 2022 - 5:22PM
UK Regulatory
TIDMCVSG
RNS Number : 6817H
CVS Group plc
25 November 2022
25 November 2022
CVS Group plc
("CVS" or the "Company")
Grant of Options under CVS Group plc SAYE Option Scheme &
PDMR Dealing
CVS Group plc (the "Company") announces that as part of its
2022/2023 Save As You Earn share scheme (the "SAYE Scheme"), which
is open to all employees of the Group, the Executive Directors
named below have elected to participate in the SAYE Scheme and have
been granted SAYE Scheme options as follows:
Richard Fairman 380 SAYE scheme options
Robin Alfonso 403 SAYE scheme options
Ben Jacklin 403 SAYE scheme options
Eligible employees were invited to subscribe for options over
the Company's ordinary shares of 0.2 pence each ("Ordinary Shares")
with an exercise price of 1,515 pence per share, representing a 20%
discount to the average closing middle market price for the three
dealing days prior to 1 November 2022, being the invitation
date.
In response to accepted invitations, a total of 381,689 SAYE
Scheme options over Ordinary Shares were granted on 25 November
2022, equating to 0.54% of the current issued ordinary share
capital. Subject to the rules of the SAYE Scheme, these options
will be capable of exercise from the maturity date on 1 January
2026.
The notification below, made in accordance with the requirements
of UK MAR, provides further detail.
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Jenny Farrer, Group Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418
8900
Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose
Berenberg (Joint Broker)
+44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser
Camarco (Financial PR)
Geoffrey Pelham-Lane +44 (0)7733 124 226
Ginny Pulbrook +44 (0)7961 315 138
Toby Strong
+44 (0)7789 151 644
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Richard Fairman
--------------------------- ------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------
a) Position/status Chief Executive Officer
--------------------------- ------------------------------------------
b) Initial notification Initial Notification
/Amendment
--------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------
a) Name CVS Group plc
--------------------------- ------------------------------------------
b) LEI 213800J41XDQ2NX48O05
--------------------------- ------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------
a) Description of Options over Ordinary shares of 0.2 pence
the financial instrument, each
type of instrument
Identification GB00B2863827
code
--------------------------- ------------------------------------------
b) Nature of the transaction Grant of Options under the SAYE Scheme.
--------------------------- ------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price
of 1,515p 380
----------
--------------------------- ------------------------------------------
d) Aggregated information
* Aggregated volume
* Price
--------------------------- ------------------------------------------
e) Date of the transaction 25 November 2022
--------------------------- ------------------------------------------
f) Place of the transaction Off market
--------------------------- ------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Robin Alfonso
--------------------------- ------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------
a) Position/status Chief Financial Officer
--------------------------- ------------------------------------------
b) Initial notification Initial Notification
/Amendment
--------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------
a) Name CVS Group plc
--------------------------- ------------------------------------------
b) LEI 213800J41XDQ2NX48O05
--------------------------- ------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------
a) Description of Options over Ordinary shares of 0.2 pence
the financial instrument, each
type of instrument
Identification GB00B2863827
code
--------------------------- ------------------------------------------
b) Nature of the transaction Grant of Options under the SAYE Scheme.
--------------------------- ------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price
of 1,515p 403
----------
--------------------------- ------------------------------------------
d) Aggregated information
* Aggregated volume
* Price
--------------------------- ------------------------------------------
e) Date of the transaction 25 November 2022
--------------------------- ------------------------------------------
f) Place of the transaction Off market
--------------------------- ------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Ben Jacklin
--------------------------- ------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------
a) Position/status Chief Operating Officer
--------------------------- ------------------------------------------
b) Initial notification Initial Notification
/Amendment
--------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------
a) Name CVS Group plc
--------------------------- ------------------------------------------
b) LEI 213800J41XDQ2NX48O05
--------------------------- ------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------
a) Description of Options over Ordinary shares of 0.2 pence
the financial instrument, each
type of instrument
Identification GB00B2863827
code
--------------------------- ------------------------------------------
b) Nature of the transaction Grant of Options under the SAYE Scheme.
--------------------------- ------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price
of 1,515p 403
----------
--------------------------- ------------------------------------------
d) Aggregated information
* Aggregated volume
* Price
--------------------------- ------------------------------------------
e) Date of the transaction 25 November 2022
--------------------------- ------------------------------------------
f) Place of the transaction Off market
--------------------------- ------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHPPGBGGUPPGQA
(END) Dow Jones Newswires
November 25, 2022 11:22 ET (16:22 GMT)
CVS (AQSE:CVSG.GB)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
CVS (AQSE:CVSG.GB)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
